Company Releases - Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Clinical Trials

Regenerative therapy for peripheral artery disease moves forward

Shaky foundations: the flaws in animal research reporting

ViiV ups the ante with positive topline data for its second two-drug HIV combo

Cold Chain

ViiV ups the ante with positive topline data for its second two-drug HIV combo

EHA 2018: can biosimilars be implemented worldwide to promote sustainability?

Eli Lilly’s Olumiant: how will it far among JAK inhibitors?

Diseases

Sugar can delay neurodegeneration caused by enzyme deficiency

Researchers identify brain metals that may precipitate Alzheimer’s

Regenerative therapy for peripheral artery disease moves forward

Drug Development

Regenerative therapy for peripheral artery disease moves forward

The launch of 10 new pipeline drugs will further intensify competition in the Dry Eye Syndrome market, says GlobalData

Natera and Institut Jules Bordet partner on breast cancer research

Manufacturing

Regenerative therapy for peripheral artery disease moves forward

The world’s biggest pharmaceutical companies by revenue in 2018

EAN Congress 2018: adaptation key to managing non-routine Parkinson’s

Market Data

Are US pharma companies immune to US–Canada trade wars?

Deals and M&As this week: Alliance Pharma, Bayer, Onxeo

Merck to distribute HistoCyte Laboratories’ cell line products

Technology

Innovators to watch from TLA’s HealthTech Innovator conference

Denali and AbCellera to collaborate on treating neurodegenerative disease

ASCO 2018: Roche’s polatuzumab vedotin results show promise in DLBCL